Novartis AG vs DENTSPLY SIRONA Inc — how do they compare? Novartis AG trades at $152.4 (market cap $295.37B), while DENTSPLY SIRONA Inc trades at $11.69 (market cap $2.31B). The key difference: Novartis AG is far larger — about 127.9× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays the higher dividend (5.04%). Which is the better fit depends on your goals.
| NVS | XRAY | |
|---|---|---|
Market Cap | $295.37B | $2.31B |
Sector | Health | Health |
52-Week High | $168.62 | $14.68 |
52-Week Low | $119.31 | $9.64 |
Enterprise Value | $336.69B | $4.39B |
Dividend Yield | 3.07% | 5.04% |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →